V-Wave Receives Second FDA Breakthrough Device Designation: Interatrial Shunt for Pulmonary Arterial Hypertension
V-Wave Receives Second FDA Breakthrough Device Designation: Interatrial Shunt [...]
Need a new search
If you didn't find what you were looking for, try a new search!
V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure
V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart [...]
William T. Abraham, Md Joins V-wave as Chief Medical Officer
William T. Abraham, Md Joins V-wave as Chief Medical Officer [...]
V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy
V-Wave Closes $70M Financing to Support Pivotal Study of [...]
Molecular Partners’ strategic partner Allergan announces that EMA has validated the marketing authorisation application for abicipar
Molecular Partners’ strategic partner Allergan announces that EMA has validated [...]